Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Subchronic treatment with the selective serotonergic reuptake inhibitors (SSRIs) fluoxetine, venlafaxine and paroxetine, but not sertraline, were previously shown to specifically impair vigilance performance. The current study was designed to compare the vigilance effects of subchronic treatment with the SSRIs sertraline and citalopram in healthy volunteers, according to a placebo-controlled, double-blind, three-way cross-over design. Twenty-four healthy subjects, aged 30-50 years, of whom 21 completed the study, underwent three treatment periods of 2 weeks in which they received sertraline (50 mg on days 1-8, 100 mg on days 8-15), citalopram (20 mg on days 1-8, 40 mg on days 8-15) and placebo. Treatment periods were separated by 14 days washout periods. Vigilance performance was assessed through a 45-min Mackworth Clock Test at days 1, 8 and 15 of each treatment period. It was found that citalopram impaired vigilance performance acutely after the first 20 mg dose and subchronically after 40 mg daily doses. By contrast, no vigilance impairment was found during sertraline treatment. Sertraline is the only SSRI studied so far with no detrimental effects on vigilance. This may be due to the affinity of sertraline for the dopamine reuptake site. Because citalopram is the most specific SSRI showing this effect, it is concluded that the SSRI-induced decrement of vigilance performance is specifically associated with serotonergic reuptake inhibition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arousal, activation, and effort in the control of attention.
Pribram, K. H., & McGuinness, D. (1975) · Psychological Review · doi:10.1037/h0076780 · Cited by 1,208 · cited 1×
“It is more likely that noradrenaline is associated with phasic arousal, whereas dopamine is more likely to be associated with a tonic readiness to respond (Pribram and McGuinness, 1975; Robbins, 1997).”
Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation.
Riedel, W. J., Klaassen, T., Deutz, N. E. P., van Someren, A., & van Praag, H. M. (1999) · Psychopharmacology · doi:10.1007/s002130050845 · Cited by 271
Self-citationAge-Related Decline of Psychomotor Speed: Effects of Age, Brain Health, Sex, and Education
Houx, P. J., & Jolles, J. (1993) · Perceptual and Motor Skills · doi:10.2466/pms.1993.76.1.195 · Cited by 172 · cited 1×
“(Houx and Jolles, 1993) This is a computerized test, in which reaction times are studied as a function of the complexity of task requirements.”
Acute administration of citalopram facilitates memory consolidation in healthy volunteers
Harmer, C. J., Bhagwagar, Z., Cowen, P. J., & Goodwin, G. M. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1151-x · Cited by 112
Levkovitz, Y., Caftori, R., Avital, A., & Richter-Levin, G. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00780-8 · Cited by 112
Ramaekers, J., Muntjewerff, N., & O'Hanlon, J. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04468.x · Cited by 103
Research works printed but not linked: 24
- 10.1016/0024-3205(93)90194-8 · DOI · Paper page
- 10.1016/S0166-4328(05)80275-X · DOI
- 10.1002/(SICI)1099-1077(199703/04)12:2<119::AID-HUP847>3.0.CO;2-W · doi:10.1002/(sici)1099-1077(199703/04)12:2<119::aid-hup847>3.0.co;2-w
- 10.1016/0165-0327(90)90079-N · DOI
- 10.1177/0269881198012003031 · DOI · Paper page
- 10.1016/S0304-3940(97)00451-5 · DOI
- Jacobs B L, 1995, Psychopharmacology: The Fourth Generation of Progress, 461
- 10.1016/S0006-3223(99)00082-7 · DOI
- Lezak M D, 1995, Neuropsychological Assessment, 3rd edn
- 10.1080/17470214808416738 · DOI · Paper page
- 10.1037/0735-7044.111.3.646 · doi:10.1037/0735-7044.111.3.646 · Paper page
- McNair D M, 1992, Manual for the Profile of Mood States (Revised). Educational and Industrial Testing Service
- Mulder-Hajonides-van-der-Meulen W R E H, International European Sleep Conference
- Nicholson A N, 1990, Alcohol Drugs Driving, 5, 287
- 10.1097/00004714-199806000-00006 · DOI · Paper page
- 10.3758/BF03342823 · DOI · Paper page
- 10.1002/(SICI)1099-1077(1998110)13:2+<S87::AID-HUP53>3.0.CO;2-8 · DOI · Paper page
- 10.1002/(SICI)1099-1077(199910)14:7<499::AID-HUP136>3.0.CO;2-1 · DOI
- 10.1016/S0893-133X(01)00361-X · DOI
- 10.1016/S0301-0511(96)05222-2 · DOI · Paper page
- 10.1177/026988110101500304 · DOI
- 10.1177/026988110201600303 · DOI · Paper page
- 10.1055/s-2001-17606 · DOI · Paper page
- 10.1001/archpsyc.1965.01720310065008 · DOI · Paper page
Cited by
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
The bright side of being blue: depression as an adaptation for analyzing complex problems.
Andrews, P. W., & Thomson, J. A. (2009) · Psychological Review · doi:10.1037/a0016242 · Cited by 549
Cognitive Mechanisms of Treatment in Depression
Roiser, J. P., Elliott, R., & Sahakian, B. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.183 · Cited by 535
Effects of tryptophan loading on human cognition, mood, and sleep
Silber, B. Y., & Schmitt, J. A. J. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.08.005 · Cited by 260
“…consistent evidence from a series of studies with serotonergic antidepressants that 5-HT stimulation (acute and sub-chronic) impairs vigilance performance in healthy volunteers as measured by the Mackworth Clock Test (Riedel et al., 2005; Wingen et al., 2008; for review see Schmitt et al., 2006).”
BackgroundMethodSelf-citationThe vigilance regulation model of affective disorders and ADHD
Hegerl, U., & Hensch, T. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.008 · Cited by 212
Metadata
- Authors
- Riedel, W. J., Eikmans, K., Heldens, A., & Schmitt, J. A. J.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2005-01
- Volume
- 19
- Issue
- 1
- Pages
- 12-20
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2162752407
- Cited by
- 73
- References
- 6
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment. https://app.cochat.ai/papers/10.1177/0269881105048887
- The paper
- Riedel, W. J., Eikmans, K., Heldens, A., & Schmitt, J. A. J. (2005). Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment. Journal of Psychopharmacology. https://doi.org/10.1177/0269881105048887
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.